Inhibikase Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $175k | 85k | 2.05 |
| 2025-09-30 | $17k | 11k | 1.62 |
| 2025-03-31 | $364k | 166k | 2.19 |
| 2024-12-31 | $143k | 44k | 3.25 |